Wisconsin health officials are concerned about a recent change to federal guidelines on the hepatitis B vaccine for newborns. For over 30 years, it’s been standard practice to vaccinate all babies at birth. But now, the Advisory Committee on Immunization Practices suggests that only babies born to mothers who test positive for the virus should receive the vaccine immediately. Those born to mothers with a negative or unknown status are advised to consult their doctors.
This shift has raised eyebrows, especially since, according to the CDC, about half of individuals infected with hepatitis B are unaware of their condition. If a baby contracts the virus within their first year, there’s a staggering 90% likelihood of developing chronic disease, which could lead to severe consequences like liver failure or cancer. The American Academy of Pediatrics estimates that 25% of these infants may not survive.
Dr. Jonathan Temte from the University of Wisconsin-Madison criticized this change, emphasizing that it isn’t based on new evidence. He warns it could confuse families and health providers alike. “This creates chaos and unnecessary concern about vaccine safety,” he stated.
Dr. Margaret Hennessy, leading the Wisconsin Chapter of the American Academy of Pediatrics, added that the previous approach encouraged shared decision-making with families. She believes that many have forgotten the serious risks posed by hepatitis B, especially since the vaccine has greatly reduced infections in newborns. She fears this change might lead to lower vaccination rates, mirroring the decline seen in other vaccines, like measles.
Maureen Busalacchi, president of the Wisconsin Public Health Association, echoed these sentiments. She noted that the federal vaccine schedule impacts insurance and state guidelines. Unclear recommendations could create barriers to access for families seeking the vaccine.
This change brings to mind historical instances in public health where shifts in recommendations have led to confusion and declines in vaccination rates. For example, after the controversial change in the measles vaccination strategy in the early 2000s, the U.S. saw a notable increase in measles cases.
Keeping the hepatitis B vaccine as a standard practice is essential. As Busalacchi points out, “The science is clear. We know this saves infants from infection, and we need to keep the policy as it is.”
The conversation around vaccination is ongoing, with public health experts reiterating the importance of clear communication to protect the most vulnerable populations in our communities.
For more on this topic, you can refer to the CDC’s hepatitis B information.
